BET inhibitors, such as JQ1 and OTX-015, competitively bind to acetyl–lysine recognition pockets, displace BET bromodomain proteins from chromatin, and inhibit the expression of oncogenes, leading to cancer cell growth inhibition and apoptosis. This evidence concerns the gene DNER and cancer.